Under-30s in the UK are to be offered an alternative Covid vaccine to the AstraZeneca jab due to the evidence linking it to rare blood clots.
The recommendation comes after a review by the UK drugs regulator found that by the end of March 79 people had suffered rare blood clots after vaccination – 19 of whom had died.
Thanks to political bufoons and a sensationalist press, a load of people will turn their nose up at a vaccine because of a possible, hypothetical and infintesimal risk of a cerebral venous sinus thrombosis. Half of them will be young women who will happily take the pill, which carries a far greater risk of causing blood clots. The risk in context:
NEW: MHRA tell me that the baseline rate of cerebral venous sinus thrombosis (CVST) is 5-16 cases per million people per year. The current rate of CVST among people who have received the AstraZeneca vaccine is 44/20,200,000 – or 2 cases per million people over 3 months.
— Ben Kentish (@BenKentish) April 7, 2021